Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Rossari Biotech Ltd

ROSSARI
NSE
467.00
0.42%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Rossari Biotech Ltd

ROSSARI
NSE
467.00
0.42%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
2,587Cr
Close
Close Price
467.00
Industry
Industry
Seeds/Tissue Culture/Bio Technology
PE
Price To Earnings
17.33
PS
Price To Sales
1.08
Revenue
Revenue
2,396Cr
Rev Gr TTM
Revenue Growth TTM
15.19%
PAT Gr TTM
PAT Growth TTM
9.42%
Peer Comparison
How does ROSSARI stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
ROSSARI
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue
RevenueCr
411483464473490498513580544586582685
Growth YoY
Revenue Growth YoY%
-5.513.619.116.319.33.110.622.611.017.613.418.2
Expenses
ExpensesCr
353420400409425432448510476514513608
Operating Profit
Operating ProfitCr
586464646566656968726977
OPM
OPM%
14.113.213.713.413.313.212.612.012.512.311.811.3
Other Income
Other IncomeCr
2141111222120
Interest Expense
Interest ExpenseCr
654344566689
Depreciation
DepreciationCr
141515161515181818182024
PBT
PBTCr
394548464748424846504364
Tax
TaxCr
101213111213111313131018
PAT
PATCr
293334343535323434373346
Growth YoY
PAT Growth YoY%
1.937.833.917.819.47.2-7.80.9-3.74.43.433.5
NPM
NPM%
7.16.87.47.27.17.16.25.96.26.35.66.7
EPS
EPS
5.36.06.26.26.36.45.76.26.16.75.98.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
5166007091,4831,6561,8312,0802,396
Growth
Revenue Growth%
16.318.2109.111.710.613.615.2
Expenses
ExpensesCr
4394955861,3001,4331,5811,8152,110
Operating Profit
Operating ProfitCr
78105124183223250265286
OPM
OPM%
15.017.417.412.413.513.612.711.9
Other Income
Other IncomeCr
1491468524
Interest Expense
Interest ExpenseCr
3431322191829
Depreciation
DepreciationCr
1217234863606779
PBT
PBTCr
6388107136144178185203
Tax
TaxCr
1823273937474953
PAT
PATCr
46658098107131136149
Growth
PAT Growth%
42.822.722.19.821.94.39.4
NPM
NPM%
8.810.911.36.66.57.16.66.2
EPS
EPS
9.413.415.617.819.523.724.726.9

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
410101111111111
Reserves
ReservesCr
1192773987949041,0371,1741,322
Current Liabilities
Current LiabilitiesCr
122149150295349425537790
Non Current Liabilities
Non Current LiabilitiesCr
4362157104100174166
Total Liabilities
Total LiabilitiesCr
2504725611,2571,3681,5721,8962,289
Current Assets
Current AssetsCr
1603263556097208441,0421,244
Non Current Assets
Non Current AssetsCr
901452076476477298541,045
Total Assets
Total AssetsCr
2504725611,2571,3681,5721,8962,289

Cash Flow

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
715748291524313765
Investing Cash Flow
Investing Cash FlowCr
-36-190-37-299-181-103-184-219
Financing Cash Flow
Financing Cash FlowCr
-29157-25292611665186
Net Cash Flow
Net Cash FlowCr
623-142232-441932
Free Cash Flow
Free Cash FlowCr
27-19-8-7120-83-21
CFO To PAT
CFO To PAT%
155.887.159.730.1141.333.1100.843.6
CFO To EBITDA
CFO To EBITDA%
91.854.338.716.068.017.351.922.8

Ratios

Consolidated
Standalone
Financial YearMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
005,3885,0303,2843,7263,3442,095
Price To Earnings
Price To Earnings
0.00.067.251.530.628.524.514.0
Price To Sales
Price To Sales
0.00.07.63.42.02.01.60.9
Price To Book
Price To Book
0.00.013.26.33.63.62.81.6
EV To EBITDA
EV To EBITDA
0.0-0.642.927.214.515.313.28.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
34.338.134.825.329.329.331.130.4
OPM
OPM%
15.017.417.412.413.513.612.711.9
NPM
NPM%
8.810.911.36.66.57.16.66.2
ROCE
ROCE%
51.926.326.918.316.816.914.513.3
ROE
ROE%
36.922.819.612.111.712.511.511.2
ROA
ROA%
18.313.814.37.87.88.37.26.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
#### **Overview** Rossari Biotech Limited is a leading Indian specialty chemicals manufacturer headquartered in Mumbai, with manufacturing facilities in Silvassa and Dahej, Gujarat. Established in 1997, the company has evolved into a diversified player offering intelligent and sustainable chemical solutions across three core segments: - **Home, Personal Care & Performance Chemicals (HPPC)** - **Textile Specialty Chemicals (TSC)** - **Animal Health and Nutrition (AHN)** It serves global industries including FMCG, textiles, personal care, agrochemicals, healthcare, pet care, and oil & gas. The company emphasizes innovation, sustainability, and customer-centricity, leveraging over 4,300 products and a robust R&D-driven model. --- #### **Corporate Leadership & Strategy** - **Promoters**: Technocrat entrepreneurs with over **45 years of combined experience** in the specialty chemicals industry. - **Growth Pillars**: Diversification, globalization, innovation, and capacity enhancement. - **Strategic Focus**: - Developing green chemistry and sustainable solutions (e.g., biosurfactants, enzyme-based formulations, NMMO). - Expanding into high-growth segments like spin finish, technical textiles, pet food, vitamin premixes, and oil & gas. - Increasing wallet share through cross-selling to MNC customers and expanding into new geographies. - Pursuing inorganic growth via acquisitions and joint ventures. --- #### **Business Segments Overview** 1. **Home, Personal Care & Performance Chemicals (HPPC)** - Core products: Surfactants, phenoxyethanol, esters, acrylic polymers, institutional hygiene solutions. - Key drivers: Demand in agrochemicals, personal care, and institutional cleaning. - Achieved **16.2% YoY growth**, added **93 new customers**, and expanded into 14 new geographies. - Developed green surfactants and biosurfactants using fermentation technology. - Launched **Dr. Nanoxa**, a nanotechnology-based antimicrobial coating with 30-day protection. - Commissions new ethoxylation capacities and expands capacity for phenoxypropanol and polyethylene glycol (PEG) powders. 2. **Textile Specialty Chemicals (TSC)** - India’s **largest manufacturer** of textile specialty chemicals. - Provides eco-friendly solutions across the entire value chain—from fiber production to garment finishing. - Offers functional finishes: antimicrobial, UV protection, water repellence, wrinkle resistance. - Innovations: Sustainable black dyeing process, enzyme-based scouring (RENEWA initiative), water-less dyeing tech. - Textile revenue grew **14% YoY**, driven by exports; domestic growth at 5–6%. - Expanding into spin finishes, textile sizing, and silicon-based lubricants. - Strong presence in export markets: Egypt, Bangladesh, Southeast Asia, North Africa. 3. **Animal Health & Nutrition (AHN)** - Established over 13 years ago; now a strategic growth vertical. - Offers over **100 products**: vitamin premixes, enzymes, acidifiers, gut health solutions. - Serves poultry, aqua feed, dairy, and pet care sectors. - Launched pet care brands: **Lozalo** (grooming), **Zippy** (pet food), **Top Tail** (feline food). - Entering therapeutic and gut health segments using bioprocess technology. - Plans to build a vitamin premix and mineral production facility. - Focused on exports to Bangladesh, Nepal, Sri Lanka, and Latin America. --- #### **Global Expansion & Distribution** - Serves **over 1,000 clients** globally across 25+ countries. - Long-standing client relationships (some exceeding **15 years**). - Export revenue now accounts for **28%** of total revenue (up from 24% in FY24), growing **36% YoY** in Q2 FY26. - **Key international markets**: - **Southeast Asia**: Indonesia, Thailand, Vietnam, Cambodia - **Middle East & Africa**: Egypt, Saudi Arabia, UAE, Turkey - **Americas**: Brazil, Peru, Colombia, USA, Russia - **Europe**: Germany, Belgium, Italy - Strategic investments: - Subsidiary **Rossari International Limited** established in **Saudi Arabia** ($8 million approved investment). - **Overseas formulation hub** being set up in **Thailand**. - Joint ventures: **Hextar Unitop (Malaysia)**, **Romakk Chemicals (India)**. - Export offices in **Vietnam, Thailand, Turkey, and Dubai**. --- #### **Manufacturing & Capacity** - Operates **7 manufacturing facilities** with a total installed capacity of **367,100 MTPA** (as of Oct 2025), up from 332,100 MTPA earlier. - Key sites: - **Dahej (I & II)**: 132,500 MTPA, near port for logistics advantage; includes 500 kW solar plant. - **Silvassa**: 120,000 MTPA, fully automated, zero liquid discharge. - Acquired capacities from **Unitop Chemicals** (64,000 MTPA) and **Tristar Intermediates** (15,000 MTPA). - **Capacity Expansion (FY25–FY26)**: - **20,000 MTPA** new capacity at Dahej. - **15,000 MTPA** ethoxylation expansion at Unitop. - **30,000 MTPA** ethoxylation capacity added to meet demand in agrochemicals, home & personal care, oil & gas, and pharma. - Backward integration: - In-house production of **surfactants**, **silicon oils**, **phenoxyethanol**, **sorbitan esters**, **choline chloride**, and **NMMO**. --- #### **Innovation & R&D** - **Four core chemistries**: Surfactants, Silicones, Acrylics, Enzymes. - Operates **four R&D centers** in Mumbai, Silvassa, and Dahej. - **Rossari Centre of Excellence** established at **IIT Bombay** (recognized by DSIR). - Over **140 new products launched** in recent years, ~18% of revenue from new products. - Focus on green chemistry: biosurfactants (Sophorolipids), bio-softeners, low-temperature processing, enzyme-based desizing. - Key innovations: - **Renewa**: Green platform for sustainable towel processing. - **Ester Quartz**: Renewable-based softener. - **Dr. Nanoxa**: Nano-antimicrobial surface coating. - **Phenoxy Propanol**: Next-gen preservative for personal care. - **PEG Powder**: Entry into pharmaceutical tablet coatings. - **NMMO**: Solvent for eco-friendly Lyocell fiber manufacturing. --- #### **Key Acquisitions & Subsidiaries (Strategic Integration)** Rossari has strengthened its portfolio through strategic acquisitions completed since 2021: | Subsidiary | Focus | Capacity | Key Highlights | |-----------|-------|--------|----------------| | **Unitop Chemicals Pvt. Ltd. (UCPL)** | Surfactants, Emulsifiers, Agrochemicals | 86,000 MTPA (as of 2023), now 64,000 MTPA post-realignment | Strong presence in 25+ countries; 50% JV with Hextar (Malaysia); key in phenoxy series and ethoxylation tech | | **Tristar Intermediates Private Ltd.** | Preservatives, Aroma Chemicals, Distillation Tech | 15,000 MTPA | Supplies MNCs; expertise in phenoxyethanol, propoxylation; key in pharma intermediates | | **Romakk Chemicals Pvt. Ltd.** | Silicone Oils, Emulsions, Lubricants | 600 MTPA | JV with McCoy & KK Chemicals; enables in-house silicon oil production | | **Buzil Rossari / Rossari Professional** | Institutional Cleaning & Hygiene | — | Rebranded; offers bundled hygiene solutions; Rs. 200 crore revenue (9MFY25) | | **Rossari Global DMCC** (UAE) | Export trading hub | — | Manages global sales via Jebel Ali Free Zone | | **Unistar Thai Co. Ltd.** (Thailand) | New manufacturing entity | — | Future expansion in Southeast Asia | | **Rossari Bangladesh** | Local entity for textile market | — | Strengthening footprint in largest export market | - Full ownership of Unitop and Tristar achieved by mid-2024. - Synergies: Cross-selling, shared tech platforms, integrated R&D, and unified go-to-market strategies. --- #### **Financial & Operational Performance** - **Revenue CAGR (FY19–FY25)**: **26%** - **PAT CAGR (FY19–FY25)**: **20%** - **Revenue Growth (FY25)**: **13.6%**, driven by HPPC, AHN, and new consumer verticals. - **New Verticals Performance** (Institutional Cleaning, B2C Hygiene): - Revenue: **₹300 crore**, up **67% YoY**. - Institutional cleaning business: Grew to **₹200 crore** in 9MFY25. - **Strong EBITDA and Margin Trends**: - Consolidated gross margins improved YoY. - Record-high EBITDA reported in FY25. - Margin pressure expected to ease as new capacities ramp up and operating leverage improves. --- #### **Competitive Positioning** - **Competes with global players** like Dow, BASF, Croda, Solvay, Archroma, Huntsman, Ecolab, and Diversey. - **Differentiators**: - Agile, fungible manufacturing. - Deep R&D and customization. - Sustainable, green chemical solutions. - Integrated supply chain and backward integration. - Localized production with global outreach. ---